Susquehanna International Group
BSTC

Susquehanna International Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Susquehanna International Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,556
Closed -$477K – 10417
2016
Q4 		$477K Buy
+8,556
New +$411K ﹤0.01% 7094
2013
Q4 		– Sell
-16,911
Closed -$329K – 9487
2013
Q3 		$329K Sell
16,911
-7,469
-31% -$132K ﹤0.01% 7080
2013
Q2 		$380K Buy
+24,380
New +$392K ﹤0.01% 6447

Other funds holding BSTC

JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Susquehanna International Group's BSTC Position: Q1 2017 in Review

Susquehanna International Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2017, closing a stake of 8,556 shares — an estimated $477K sold.

Susquehanna International Group first reported a position in BSTC in Q2 2013 and held it in 3 quarters. The position peaked at $477K in Q4 2016. 89 funds tracked by Wall St. Rank hold BSTC as of Q1 2017.

  • Susquehanna International Group reported no remaining BioSpecifics Technologies Corp. position as of Q1 2017 after selling out during the quarter.
  • Susquehanna International Group sold 8,556 BioSpecifics Technologies Corp. shares in Q1 2017, an estimated $477K.
  • Susquehanna International Group first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 3 quarters.
  • Susquehanna International Group's BioSpecifics Technologies Corp. position peaked at $477K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.